Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Placebo-controlled, double-blind, randomized study of Aerucin as adjunct to standard antibiotics in Pseudomonas aeruginosa pneumonia
2016-004261-10Phase 2Completed
- Sponsor
- Aridis Pharmaceuticals, Inc.
- Start
- Mar 2017
- Modality
- Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ceftazidime in Pseudomonas pneumonia, pneumonia, sponsored by Aridis Pharmaceuticals, Inc.. Started Mar 2017; status: completed.
02
Drugs
ceftazidime
03
Conditions
Pseudomonas pneumoniapneumonia
Beyond the preview
Go deeper on 2016-004261-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004261-10.